Legal and regulatory issues have a growing impact on how radiologists perform procedures and studies, report results, and structure their practices. Implementing a simple checklist may help to reduce the prospect of being sued for malpractice.

Results from the largest and longest trial of its kind suggest that patients with intermediate and advanced hepatocellular carcinomas who undergo systematic treatment with three chemotherapeutic agents and arterial embolization plus imaging follow-up have better survival rates than those who undergo nonstandardized chemoembolization regimes.

The imminent publication of eagerly anticipated new international guidelines promises to transform the complex area of lung cancer staging.

Prostate-specific antigen measurements are considered a useful organ-specific marker, but they are not necessarily an adequate tumor marker. PET/CT in combination with PSA levels can play a significant role in detecting and staging prostate cancer, according to two presentations Sunday at RSNA 2008.

A new technique may help characterize diffusion anisotropy in the spinal cord in a clinical setting. Researchers have determined that using 3D single-shot diffusion-weighted stimulated echo-planar imaging in the cervical spinal cord results in higher resolution and less distortion than 2D single-shot diffusion-weighted echo-planar imaging.

Lifelong learning in an era of globalized healthcare science and practice is essential, according to Sunday’s opening session of RSNA 2008, which also stressed the need for standardization in training and certification.

Elastrography forms the cornerstone of an ultrasound system unveiled by first-time RSNA exhibitor SuperSonic Imagine. The Aixplorer system is dedicated to breast imaging. It differentiates healthy from cancerous tissues by quantifying differences in the elasticity of the tissues. SuperSonic’s ShearWave Elastography technique produces consistent results regardless of the operator’s skill, according to the company.

Enhancements in breast imaging mark the latest ultrasound upgrade from Philips Healthcare. Tissue aberration correction technology and algorithms built into the Vision 2009 upgrade for its iU22 radiological flagship are part of an integrated effort to better define tissue in fatty breasts, according to the company. An enabling technology is the Philips PureWave transducer and its coded beamformer, which have been present on earlier technologies.

PET niche developer Naviscan arrived at the RSNA meeting with permission from the FDA to launch its Stereo Navigator, a biopsy guidance feature for its breast-specific PET scanner. Stereo Navigator can localize lesions as small as 2 mm. It uses a stereotactic frame fixed between the scanner’s paddles to guide a biopsy needle into the breast. Localization is verified using a PET-visible line source inserted into the needle track. This allows the user to confirm trajectory and position. The PET-guidance accessory is compatible with biopsy devices from Ethicon Endo-Surgery, Hologic, and SenoRx.

Invivo introduced at RSNA 2008 its sixth-generation vital signs monitor for use in MR suites. The Precess Patient Management Configuration uses the industry’s first wireless ECG and wireless SpO₂ patient vital signs. Built on the company’s flagship Precess 3160 platform, the new system features a flexible mounting that allows attachment to anesthesia machines, a wall, or an MRI table.